Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Wow

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Jan 27, 2021 11:03am

46 Views

Post# 32398758

RE:Wow

Last time I checked were in the midst of a major Covid Pandemic.....how can markets possibly just keep going up ....

This siuation isn't good for the economy thats a for sure....now travel restrictions are tightning up and death rates are still raising ....the only sectors that should be doing well is Bio-technology

Where is most goverment money going right now ??? Hint....... Healthcare